252 related articles for article (PubMed ID: 17052812)
21. [Immune response and protective efficacy in BALB/c mice induced by DNA vaccine encoding immunogenic protein of Legionella pneumophila].
Yang ZW; Chen JP; Wang T; Tian Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):209-12. PubMed ID: 17343784
[TBL] [Abstract][Full Text] [Related]
22. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.
Ismael AB; Hedhli D; Cérède O; Lebrun M; Dimier-Poisson I; Mévélec MN
Vaccine; 2009 May; 27(22):2959-66. PubMed ID: 19428907
[TBL] [Abstract][Full Text] [Related]
23. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
[TBL] [Abstract][Full Text] [Related]
25. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
26. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
[TBL] [Abstract][Full Text] [Related]
27. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
Huang Y; Chen A; Li X; Chen Z; Zhang W; Song Y; Gurner D; Gardiner D; Basu S; Ho DD; Tsuji M
Vaccine; 2008 Mar; 26(15):1807-16. PubMed ID: 18329757
[TBL] [Abstract][Full Text] [Related]
29. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification.
Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A
Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045
[TBL] [Abstract][Full Text] [Related]
30. Mannan-mediated gene delivery for cancer immunotherapy.
Tang CK; Lodding J; Minigo G; Pouniotis DS; Plebanski M; Scholzen A; McKenzie IF; Pietersz GA; Apostolopoulos V
Immunology; 2007 Mar; 120(3):325-35. PubMed ID: 17328786
[TBL] [Abstract][Full Text] [Related]
31. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
[TBL] [Abstract][Full Text] [Related]
32. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
Cui Z; Mumper RJ
J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273
[TBL] [Abstract][Full Text] [Related]
33. Antigen epitope-expressing cytokines for DNA immunization.
He X; Tsang TC; Zhang T; Luo P; Harris DT
Vaccine; 2005 Mar; 23(16):1966-72. PubMed ID: 15734069
[TBL] [Abstract][Full Text] [Related]
34. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the components of the humoral immune response elicited by DNA vaccines.
Rush CM; Mitchell TJ; Burke B; Garside P
Vaccine; 2006 Feb; 24(6):776-84. PubMed ID: 16198029
[TBL] [Abstract][Full Text] [Related]
36. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
[TBL] [Abstract][Full Text] [Related]
37. Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer.
Lin CC; Yen MC; Lin CM; Huang SS; Yang HJ; Chow NH; Lai MD
J Gene Med; 2008 Jun; 10(6):679-89. PubMed ID: 18324638
[TBL] [Abstract][Full Text] [Related]
38. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
39. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines.
Carstens MG; Camps MG; Henriksen-Lacey M; Franken K; Ottenhoff TH; Perrie Y; Bouwstra JA; Ossendorp F; Jiskoot W
Vaccine; 2011 Jun; 29(29-30):4761-70. PubMed ID: 21565240
[TBL] [Abstract][Full Text] [Related]
40. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
